nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Sorafenib—thyroid cancer	0.126	0.293	CbGbCtD
Guanfacine—CYP2C9—Sorafenib—thyroid cancer	0.105	0.244	CbGbCtD
Guanfacine—CYP3A4—Vandetanib—thyroid cancer	0.101	0.235	CbGbCtD
Guanfacine—CYP3A4—Sorafenib—thyroid cancer	0.0611	0.142	CbGbCtD
Guanfacine—CYP3A4—Doxorubicin—thyroid cancer	0.0371	0.086	CbGbCtD
Guanfacine—Abdominal pain lower—Sorafenib—thyroid cancer	0.0235	0.0413	CcSEcCtD
Guanfacine—Testicular disorder—Epirubicin—thyroid cancer	0.0159	0.028	CcSEcCtD
Guanfacine—Testicular disorder—Doxorubicin—thyroid cancer	0.0147	0.0259	CcSEcCtD
Guanfacine—Lethargy—Vandetanib—thyroid cancer	0.00819	0.0144	CcSEcCtD
Guanfacine—Skin exfoliation—Sorafenib—thyroid cancer	0.00712	0.0125	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00708	0.0125	CcSEcCtD
Guanfacine—Dysphagia—Vandetanib—thyroid cancer	0.00694	0.0122	CcSEcCtD
Guanfacine—Retrosternal pain—Epirubicin—thyroid cancer	0.00685	0.012	CcSEcCtD
Guanfacine—Pollakiuria—Vandetanib—thyroid cancer	0.00641	0.0113	CcSEcCtD
Guanfacine—Retrosternal pain—Doxorubicin—thyroid cancer	0.00633	0.0111	CcSEcCtD
Guanfacine—Conjunctivitis—Vandetanib—thyroid cancer	0.00601	0.0106	CcSEcCtD
Guanfacine—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00597	0.0105	CcSEcCtD
Guanfacine—Renal failure acute—Sorafenib—thyroid cancer	0.00587	0.0103	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00574	0.0101	CcSEcCtD
Guanfacine—Bradycardia—Vandetanib—thyroid cancer	0.00565	0.00994	CcSEcCtD
Guanfacine—Pain in extremity—Sorafenib—thyroid cancer	0.00542	0.00952	CcSEcCtD
Guanfacine—Visual impairment—Vandetanib—thyroid cancer	0.00535	0.00941	CcSEcCtD
Guanfacine—Eye disorder—Vandetanib—thyroid cancer	0.00519	0.00913	CcSEcCtD
Guanfacine—Abdominal pain upper—Sorafenib—thyroid cancer	0.00495	0.0087	CcSEcCtD
Guanfacine—Alopecia—Vandetanib—thyroid cancer	0.00491	0.00863	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00478	0.0084	CcSEcCtD
Guanfacine—Dysgeusia—Vandetanib—thyroid cancer	0.00474	0.00833	CcSEcCtD
Guanfacine—Dysphagia—Sorafenib—thyroid cancer	0.00468	0.00823	CcSEcCtD
Guanfacine—Muscle spasms—Vandetanib—thyroid cancer	0.00465	0.00817	CcSEcCtD
Guanfacine—Vision blurred—Vandetanib—thyroid cancer	0.00456	0.00801	CcSEcCtD
Guanfacine—Tremor—Vandetanib—thyroid cancer	0.00453	0.00797	CcSEcCtD
Guanfacine—Abdominal discomfort—Sorafenib—thyroid cancer	0.00449	0.00789	CcSEcCtD
Guanfacine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00431	0.00758	CcSEcCtD
Guanfacine—Loss of consciousness—Vandetanib—thyroid cancer	0.00425	0.00747	CcSEcCtD
Guanfacine—Convulsion—Vandetanib—thyroid cancer	0.00419	0.00737	CcSEcCtD
Guanfacine—Hypertension—Vandetanib—thyroid cancer	0.00417	0.00734	CcSEcCtD
Guanfacine—Arthralgia—Vandetanib—thyroid cancer	0.00412	0.00724	CcSEcCtD
Guanfacine—Chest pain—Vandetanib—thyroid cancer	0.00412	0.00724	CcSEcCtD
Guanfacine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00411	0.00723	CcSEcCtD
Guanfacine—Anxiety—Vandetanib—thyroid cancer	0.0041	0.00721	CcSEcCtD
Guanfacine—Myocardial infarction—Sorafenib—thyroid cancer	0.00409	0.00719	CcSEcCtD
Guanfacine—Hypokinesia—Epirubicin—thyroid cancer	0.00408	0.00718	CcSEcCtD
Guanfacine—Dry mouth—Vandetanib—thyroid cancer	0.00403	0.00708	CcSEcCtD
Guanfacine—Oedema—Vandetanib—thyroid cancer	0.00395	0.00694	CcSEcCtD
Guanfacine—Hypokinesia—Doxorubicin—thyroid cancer	0.00378	0.00665	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0036	0.00632	CcSEcCtD
Guanfacine—Insomnia—Vandetanib—thyroid cancer	0.00357	0.00628	CcSEcCtD
Guanfacine—Paraesthesia—Vandetanib—thyroid cancer	0.00354	0.00623	CcSEcCtD
Guanfacine—Dyspnoea—Vandetanib—thyroid cancer	0.00352	0.00619	CcSEcCtD
Guanfacine—Tinnitus—Sorafenib—thyroid cancer	0.00349	0.00614	CcSEcCtD
Guanfacine—Dyspepsia—Vandetanib—thyroid cancer	0.00347	0.00611	CcSEcCtD
Guanfacine—Decreased appetite—Vandetanib—thyroid cancer	0.00343	0.00603	CcSEcCtD
Guanfacine—Fatigue—Vandetanib—thyroid cancer	0.0034	0.00598	CcSEcCtD
Guanfacine—Immune system disorder—Sorafenib—thyroid cancer	0.00338	0.00595	CcSEcCtD
Guanfacine—Constipation—Vandetanib—thyroid cancer	0.00337	0.00593	CcSEcCtD
Guanfacine—Alopecia—Sorafenib—thyroid cancer	0.00331	0.00582	CcSEcCtD
Guanfacine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00323	0.00567	CcSEcCtD
Guanfacine—Dysgeusia—Sorafenib—thyroid cancer	0.00319	0.00562	CcSEcCtD
Guanfacine—Muscle spasms—Sorafenib—thyroid cancer	0.00314	0.00551	CcSEcCtD
Guanfacine—Abdominal pain—Vandetanib—thyroid cancer	0.00312	0.00549	CcSEcCtD
Guanfacine—Nocturia—Epirubicin—thyroid cancer	0.00297	0.00523	CcSEcCtD
Guanfacine—Syncope—Sorafenib—thyroid cancer	0.00293	0.00514	CcSEcCtD
Guanfacine—Loss of consciousness—Sorafenib—thyroid cancer	0.00287	0.00504	CcSEcCtD
Guanfacine—Atrioventricular block—Epirubicin—thyroid cancer	0.00284	0.005	CcSEcCtD
Guanfacine—Asthenia—Vandetanib—thyroid cancer	0.00283	0.00498	CcSEcCtD
Guanfacine—Hypertension—Sorafenib—thyroid cancer	0.00282	0.00495	CcSEcCtD
Guanfacine—Pruritus—Vandetanib—thyroid cancer	0.00279	0.00491	CcSEcCtD
Guanfacine—Myalgia—Sorafenib—thyroid cancer	0.00278	0.00488	CcSEcCtD
Guanfacine—Arthralgia—Sorafenib—thyroid cancer	0.00278	0.00488	CcSEcCtD
Guanfacine—Nocturia—Doxorubicin—thyroid cancer	0.00275	0.00484	CcSEcCtD
Guanfacine—Dry mouth—Sorafenib—thyroid cancer	0.00272	0.00478	CcSEcCtD
Guanfacine—Diarrhoea—Vandetanib—thyroid cancer	0.0027	0.00475	CcSEcCtD
Guanfacine—Skin exfoliation—Epirubicin—thyroid cancer	0.00263	0.00463	CcSEcCtD
Guanfacine—Atrioventricular block—Doxorubicin—thyroid cancer	0.00263	0.00463	CcSEcCtD
Guanfacine—Shock—Sorafenib—thyroid cancer	0.00262	0.00461	CcSEcCtD
Guanfacine—Dizziness—Vandetanib—thyroid cancer	0.00261	0.00459	CcSEcCtD
Guanfacine—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00253	0.00445	CcSEcCtD
Guanfacine—Vomiting—Vandetanib—thyroid cancer	0.00251	0.00441	CcSEcCtD
Guanfacine—Rash—Vandetanib—thyroid cancer	0.00249	0.00438	CcSEcCtD
Guanfacine—Dermatitis—Vandetanib—thyroid cancer	0.00249	0.00437	CcSEcCtD
Guanfacine—Headache—Vandetanib—thyroid cancer	0.00247	0.00435	CcSEcCtD
Guanfacine—Skin exfoliation—Doxorubicin—thyroid cancer	0.00244	0.00428	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00243	0.00426	CcSEcCtD
Guanfacine—Dyspnoea—Sorafenib—thyroid cancer	0.00237	0.00417	CcSEcCtD
Guanfacine—Nausea—Vandetanib—thyroid cancer	0.00234	0.00412	CcSEcCtD
Guanfacine—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00234	0.00412	CcSEcCtD
Guanfacine—Dyspepsia—Sorafenib—thyroid cancer	0.00234	0.00412	CcSEcCtD
Guanfacine—Decreased appetite—Sorafenib—thyroid cancer	0.00231	0.00407	CcSEcCtD
Guanfacine—Fatigue—Sorafenib—thyroid cancer	0.0023	0.00404	CcSEcCtD
Guanfacine—Constipation—Sorafenib—thyroid cancer	0.00228	0.004	CcSEcCtD
Guanfacine—Vascular purpura—Epirubicin—thyroid cancer	0.00224	0.00393	CcSEcCtD
Guanfacine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00221	0.00388	CcSEcCtD
Guanfacine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00218	0.00383	CcSEcCtD
Guanfacine—Renal failure acute—Epirubicin—thyroid cancer	0.00217	0.00381	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00212	0.00373	CcSEcCtD
Guanfacine—Abdominal pain—Sorafenib—thyroid cancer	0.0021	0.0037	CcSEcCtD
Guanfacine—Purpura—Epirubicin—thyroid cancer	0.00208	0.00365	CcSEcCtD
Guanfacine—Vascular purpura—Doxorubicin—thyroid cancer	0.00207	0.00364	CcSEcCtD
Guanfacine—Lethargy—Epirubicin—thyroid cancer	0.00204	0.00359	CcSEcCtD
Guanfacine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00204	0.00359	CcSEcCtD
Guanfacine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00204	0.00359	CcSEcCtD
Guanfacine—Renal failure acute—Doxorubicin—thyroid cancer	0.00201	0.00353	CcSEcCtD
Guanfacine—Pain in extremity—Epirubicin—thyroid cancer	0.002	0.00352	CcSEcCtD
Guanfacine—Affect lability—Epirubicin—thyroid cancer	0.00197	0.00346	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00196	0.00345	CcSEcCtD
Guanfacine—Hypersensitivity—Sorafenib—thyroid cancer	0.00196	0.00345	CcSEcCtD
Guanfacine—Purpura—Doxorubicin—thyroid cancer	0.00192	0.00338	CcSEcCtD
Guanfacine—Asthenia—Sorafenib—thyroid cancer	0.00191	0.00336	CcSEcCtD
Guanfacine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00189	0.00332	CcSEcCtD
Guanfacine—Lethargy—Doxorubicin—thyroid cancer	0.00189	0.00332	CcSEcCtD
Guanfacine—Pruritus—Sorafenib—thyroid cancer	0.00188	0.00331	CcSEcCtD
Guanfacine—Pain in extremity—Doxorubicin—thyroid cancer	0.00185	0.00326	CcSEcCtD
Guanfacine—Liver function test abnormal—Epirubicin—thyroid cancer	0.00185	0.00325	CcSEcCtD
Guanfacine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00183	0.00321	CcSEcCtD
Guanfacine—Abdominal pain upper—Epirubicin—thyroid cancer	0.00183	0.00321	CcSEcCtD
Guanfacine—Affect lability—Doxorubicin—thyroid cancer	0.00182	0.00321	CcSEcCtD
Guanfacine—Diarrhoea—Sorafenib—thyroid cancer	0.00182	0.0032	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00177	0.0031	CcSEcCtD
Guanfacine—Dizziness—Sorafenib—thyroid cancer	0.00176	0.0031	CcSEcCtD
Guanfacine—Dysphagia—Epirubicin—thyroid cancer	0.00173	0.00304	CcSEcCtD
Guanfacine—Asthma—Epirubicin—thyroid cancer	0.00173	0.00304	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00171	0.00301	CcSEcCtD
Guanfacine—Vomiting—Sorafenib—thyroid cancer	0.00169	0.00298	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00169	0.00297	CcSEcCtD
Guanfacine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00169	0.00297	CcSEcCtD
Guanfacine—Rash—Sorafenib—thyroid cancer	0.00168	0.00295	CcSEcCtD
Guanfacine—Dermatitis—Sorafenib—thyroid cancer	0.00168	0.00295	CcSEcCtD
Guanfacine—Headache—Sorafenib—thyroid cancer	0.00167	0.00293	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00163	0.00287	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—thyroid cancer	0.0016	0.00281	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—thyroid cancer	0.0016	0.00281	CcSEcCtD
Guanfacine—Pollakiuria—Epirubicin—thyroid cancer	0.0016	0.00281	CcSEcCtD
Guanfacine—Nausea—Sorafenib—thyroid cancer	0.00158	0.00278	CcSEcCtD
Guanfacine—Weight increased—Epirubicin—thyroid cancer	0.00157	0.00277	CcSEcCtD
Guanfacine—Drowsiness—Epirubicin—thyroid cancer	0.00154	0.00271	CcSEcCtD
Guanfacine—Conjunctivitis—Epirubicin—thyroid cancer	0.0015	0.00264	CcSEcCtD
Guanfacine—Sweating—Epirubicin—thyroid cancer	0.00148	0.0026	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—thyroid cancer	0.00148	0.0026	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—thyroid cancer	0.00146	0.00256	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—thyroid cancer	0.00143	0.00251	CcSEcCtD
Guanfacine—Bradycardia—Epirubicin—thyroid cancer	0.00141	0.00248	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—thyroid cancer	0.00139	0.00244	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—thyroid cancer	0.00139	0.00244	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—thyroid cancer	0.00137	0.00241	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—thyroid cancer	0.00133	0.00235	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—thyroid cancer	0.0013	0.00229	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—thyroid cancer	0.00129	0.00228	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—thyroid cancer	0.00129	0.00227	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—thyroid cancer	0.00128	0.00226	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—thyroid cancer	0.00125	0.0022	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—thyroid cancer	0.00123	0.00217	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—thyroid cancer	0.00122	0.00215	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—thyroid cancer	0.0012	0.00211	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—thyroid cancer	0.00119	0.0021	CcSEcCtD
Guanfacine—Tension—Epirubicin—thyroid cancer	0.00118	0.00208	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—thyroid cancer	0.00118	0.00208	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—thyroid cancer	0.00117	0.00206	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—thyroid cancer	0.00116	0.00204	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—thyroid cancer	0.00116	0.00203	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—thyroid cancer	0.00114	0.002	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—thyroid cancer	0.00113	0.00199	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—thyroid cancer	0.00112	0.00197	CcSEcCtD
Guanfacine—Agitation—Epirubicin—thyroid cancer	0.00111	0.00195	CcSEcCtD
Guanfacine—Tension—Doxorubicin—thyroid cancer	0.00109	0.00192	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—thyroid cancer	0.00109	0.00192	CcSEcCtD
Guanfacine—Malaise—Epirubicin—thyroid cancer	0.00109	0.00191	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—thyroid cancer	0.00108	0.0019	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—thyroid cancer	0.00108	0.0019	CcSEcCtD
Guanfacine—Syncope—Epirubicin—thyroid cancer	0.00108	0.0019	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—thyroid cancer	0.00107	0.00189	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—thyroid cancer	0.00107	0.00187	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—thyroid cancer	0.00106	0.00186	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—thyroid cancer	0.00105	0.00185	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—thyroid cancer	0.00104	0.00184	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—thyroid cancer	0.00104	0.00183	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00103	0.00182	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—thyroid cancer	0.00103	0.0018	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—thyroid cancer	0.00103	0.0018	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—thyroid cancer	0.00103	0.0018	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—thyroid cancer	0.00102	0.0018	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—thyroid cancer	0.00102	0.0018	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—thyroid cancer	0.00101	0.00178	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—thyroid cancer	0.00101	0.00177	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—thyroid cancer	0.001	0.00176	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—thyroid cancer	0.001	0.00176	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—thyroid cancer	0.001	0.00176	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—thyroid cancer	0.000992	0.00174	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—thyroid cancer	0.000986	0.00173	CcSEcCtD
Guanfacine—Oedema—Epirubicin—thyroid cancer	0.000984	0.00173	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00098	0.00172	CcSEcCtD
Guanfacine—Shock—Epirubicin—thyroid cancer	0.000968	0.0017	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—thyroid cancer	0.000966	0.0017	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—thyroid cancer	0.000963	0.00169	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—thyroid cancer	0.00096	0.00169	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000951	0.00167	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—thyroid cancer	0.00095	0.00167	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—thyroid cancer	0.00095	0.00167	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—thyroid cancer	0.00095	0.00167	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—thyroid cancer	0.000946	0.00166	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—thyroid cancer	0.000938	0.00165	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—thyroid cancer	0.000929	0.00163	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—thyroid cancer	0.000919	0.00162	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—thyroid cancer	0.000918	0.00161	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—thyroid cancer	0.00091	0.0016	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000896	0.00158	CcSEcCtD
Guanfacine—Shock—Doxorubicin—thyroid cancer	0.000896	0.00157	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—thyroid cancer	0.00089	0.00156	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—thyroid cancer	0.000888	0.00156	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—thyroid cancer	0.000883	0.00155	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00088	0.00155	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—thyroid cancer	0.000877	0.00154	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—thyroid cancer	0.000875	0.00154	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—thyroid cancer	0.000866	0.00152	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—thyroid cancer	0.000855	0.0015	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—thyroid cancer	0.000851	0.0015	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—thyroid cancer	0.000848	0.00149	CcSEcCtD
Guanfacine—Constipation—Epirubicin—thyroid cancer	0.000841	0.00148	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000829	0.00146	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—thyroid cancer	0.000823	0.00145	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—thyroid cancer	0.000817	0.00144	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—thyroid cancer	0.000812	0.00143	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—thyroid cancer	0.000811	0.00143	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—thyroid cancer	0.000809	0.00142	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000804	0.00141	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—thyroid cancer	0.000801	0.00141	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—thyroid cancer	0.000791	0.00139	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—thyroid cancer	0.000785	0.00138	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—thyroid cancer	0.000778	0.00137	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—thyroid cancer	0.000778	0.00137	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—thyroid cancer	0.00075	0.00132	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000744	0.00131	CcSEcCtD
Guanfacine—Hypersensitivity—Epirubicin—thyroid cancer	0.000725	0.00127	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—thyroid cancer	0.00072	0.00127	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—thyroid cancer	0.000706	0.00124	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—thyroid cancer	0.000696	0.00122	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—thyroid cancer	0.000673	0.00118	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000671	0.00118	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—thyroid cancer	0.000653	0.00115	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—thyroid cancer	0.000651	0.00114	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—thyroid cancer	0.000644	0.00113	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—thyroid cancer	0.000626	0.0011	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—thyroid cancer	0.000623	0.0011	CcSEcCtD
Guanfacine—Rash—Epirubicin—thyroid cancer	0.00062	0.00109	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—thyroid cancer	0.00062	0.00109	CcSEcCtD
Guanfacine—Headache—Epirubicin—thyroid cancer	0.000616	0.00108	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—thyroid cancer	0.000602	0.00106	CcSEcCtD
Guanfacine—Nausea—Epirubicin—thyroid cancer	0.000584	0.00103	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—thyroid cancer	0.000579	0.00102	CcSEcCtD
Guanfacine—Rash—Doxorubicin—thyroid cancer	0.000574	0.00101	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—thyroid cancer	0.000573	0.00101	CcSEcCtD
Guanfacine—Headache—Doxorubicin—thyroid cancer	0.00057	0.001	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—thyroid cancer	0.000541	0.000951	CcSEcCtD
